View our latest research stories.

Sabrina Assoumou poses in front of and points to the billboard that talks about staying up to date with covid and flu vaccines.
June 14, 2024 Profile Feature

Off-hours with Sabrina A. Assoumou, an Infectious Diseases Clinician-investigator and Boston Runner

In recent years, CHERISH Research Affiliate Sabrina A. Assoumou has become a familiar face in Boston and a trusted voice in the scientific community. An infectious diseases physician and clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine and the Center for Infectious Diseases at Boston Medical Center, Assoumou appeared in local and […]

Collaged image of a portrait of Ali Jalali, oral medication, and two individuals collaborating.
June 13, 2024 Research Highlights

Informing Evidence-Based Medicine for Opioid Use Disorder Using Pharmacoeconomic Studies

Since 2021, over 100,000 individuals have died each year from a drug overdose, with approximately 76 percent of those deaths involving opioids.  As the US health care system contends with this growing health crisis, improved access to evidence-based medication treatment for opioid use disorder (OUD) is imperative. Pharmacoeconomics, a branch of health economics used to evaluate comparative clinical, person-centered, and economic outcomes […]

May 2, 2024 Research Highlights

Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus

Children with perinatally acquired hepatitis C virus (HCV) are now eligible to receive direct-acting antivirals (DAAs), a highly effective treatment for HCV, as early as the age of 3. Despite existing studies demonstrating DAA’s high efficacy and tolerance among adults and children between the 3 and 12 years old, there has been low uptake due […]

April 17, 2024 Research Highlights

7 Ways to Improve an Already Effective Treatment for Stimulant Use Disorder

The opioid epidemic has been one of the most pressing and challenging issues that the U.S. has faced in recent decades, with countless lives lost to this devastating crisis. Now, stimulant-related overdoses are among the next big drug-related concerns, with recent studies showing that the mortality rate linked to stimulant use in the U.S. has […]

April 8, 2024 Research Highlights

Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review

In this systematic literature review published in Value in Health, CHERISH Research Affiliates Czarina Behrends and Ahmed Bayoumi, CHERISH staff members Jared Leff, Jazmine Li, and Erminia Fardone, CHERISH investigators Kathryn McCollister, Sean M. Murphy, and Bruce Schackman, and former NIDA summer intern, Weston Lowry, analyzed 16 studies that summarized and identified gaps of economic […]

a lit candle is seen against a dark background
April 2, 2024 Research Highlights

New Study Reveals Preventable-Suicide Risk Profiles

Individuals with physical health concerns made up the largest and fastest growing of five subgroups of individuals who died by suicide n the United States over roughly twenty years, according to an analysis led by Weill Cornell Medicine in collaboration with Columbia University, UC Berkeley School of Public Health, the University of Hong Kong and […]

March 8, 2024 Research Highlights

Surgeons Are Closer to Predicting Which Patients Need Post-Surgery Opioids—and Which Ones Don’t

Opioids are routinely prescribed to patients after a surgery—whether they use them or not. A new study, led by LDI Senior Fellow Anish Agarwal will help tailor prescribing so patients get the right amount of opioid medications; not too little and not too much. Unused opioids are a particular problem. Opioid misuse can start when extra tablets […]

March 8, 2024 Research Highlights

Chart of the Day: Rise in Patients with Opioid Use Disorder Leaving Hospital Prematurely

LDI Senior and Associate Fellows Ashish Thakrar, Margaret (Maggie) Lowenstein, Ryan Greysen, and M. Kit Delgado found that more people with opioid use disorder are leaving the hospital prematurely (or before medically advised), compared to marginal increases for individuals admitted for other reasons. In the study, “Trends in Before Medically Advised Discharges for Patients with Opioid Use Disorder, 2016-2020,” […]

March 8, 2024 Collaborations

Back in Person and Taking a Bite of the Big Apple

Over the course of three days, from October 18-20, 2023, the annual Addiction Health Services Research (AHSR) Conference brought over 300 attendees to Roosevelt Island in New York City to share new addiction research findings, learn about the field through pre-conference workshops, develop collaborative relationships, and support early-career and under-represented investigators. “I am so proud […]

February 29, 2024 Collaborations

Sharing Your Research for Maximum Impact

In today’s digital and media landscape, there are several ways to disseminate your health economics research after its publication. From our experience, writing social media, news posts, and policy briefs has allowed us to convey study findings from different angles, reach new audiences, and inform key decision makers. As you are preparing your next journal […]

February 21, 2024 Collaborations

Stigma and Sluggish Bureaucracy Block Treatment for Stimulant Use Disorder

So, imagine there’s a runaway epidemic of overdose deaths that involve non-opioid drugs and that we’ve had an evidence-based therapy for this unique addiction for the last forty years—but for reasons largely grounded in legislators’ and the public’s visceral disdain for people who use substances, we have refused to nationally recognize or widely implement this […]

Grid image of moderators and speakers who took part in the convening.
February 8, 2024 Collaborations

Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management

On January 19th, 2024, CHERISH and the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), co-hosted a virtual convening titled Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management. Contingency management is a proven and promising treatment for specific substance use disorders, especially stimulant use disorder. However, significant gaps in knowledge regarding the […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.